g.haaland
TL3 Regular · Poznań, PL
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 13 November 2024 · last posted 4d · groups: analytical-chemists, translators
158 posts, newest first. Showing up to 150.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #105 · Start Here › Welcome · 24 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #68 · Clinical › Prescriber conversations · 23 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. It took me longer than it…
-
Transit times by route, from a logged dataset Replied, post #22 · Sourcing › Logistics · 20 Jul 2026 · 0 likes I would keep transit times and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
-
Submitting a sample: the process end to end Replied, post #91 · Sourcing › Independent verification · 18 Jul 2026 · 13 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #5 · Compounds › Oral incretins · 17 Jul 2026 · 3 likes Post #3 and I disagree about the size of the effect, not about the direction. Fasting instructions are not optional advice. Taking the tablet with food or with more…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #92 · Compounds › Repair & healing peptides · 16 Jul 2026 · 0 likes Picking up post #91: that is the part I would want checked first. I have three months of notes on Stability of BPC-157 and the honest summary is that the trend is real…
-
Prescription portability between countries Replied, post #100 · Access › International · 15 Jul 2026 · 26 likes Everything in post #99 holds. The case it does not cover is the one I have. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #25 · Evidence › Preprints · 15 Jul 2026 · 3 likes Community labels: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #66 · Practice › Dosing & titration · 15 Jul 2026 · 2 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #58 · Outcomes › Body composition · 14 Jul 2026 · 22 likes Where I part company with post #54, and it is a narrow parting. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #85 · Practice › Interactions · 14 Jul 2026 · 0 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #38 · Start Here › Welcome · 13 Jul 2026 · 3 likes The reason Reading order keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
What to include when your question involves a chromatogram — one year on Replied, post #74 · Start Here › How to Ask · 12 Jul 2026 · 0 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Priming a pen and whether the primed volume is wasted Replied, post #2 · Devices › Pens & autoinjectors · 11 Jul 2026 · 6 likes The opening post answers the question as asked. The question underneath it is different. Air in a cartridge behaves differently from air in a syringe because the…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #12 · Start Here › How to Ask · 10 Jul 2026 · 2 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #76 · Sourcing › Red flags · 6 Jul 2026 · 0 likes Everything in post #72 holds. The case it does not cover is the one I have. Nothing here should be read as an accusation against a named company, and the guidelines…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #5 · Access › Insurance & coverage · 6 Jul 2026 · 25 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #50 · Analytics › Impurities & related substances · 5 Jul 2026 · 26 likes Storage-related degradation and synthesis-related impurity look different on a chromatogram. A growing oxidation peak over time is not a manufacturing finding.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #12 · Practice › Side effects · 29 Jun 2026 · 3 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Journal club: what we got wrong in an earlier session Replied, post #32 · Evidence › Journal club · 27 Jun 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Two people can…
-
Electrolyte supplements: which ones do anything Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 26 Jun 2026 · 4 likes Adding the measurement that post #37 says would settle it. What I would want before treating electrolyte supplements as settled: the method, the sample, and whether…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #45 · Clinical › Bloodwork · 17 Jun 2026 · 21 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #73 · Compounds › Repair & healing peptides · 16 Jun 2026 · 9 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Asking a follow-up: new topic or new reply? Replied, post #5 · Start Here › How to Ask · 9 Jun 2026 · 0 likes Taking post #4 at face value and following it one step further. If you are asking about a document, quote the exact wording of the line you are asking about.…
-
Tracking a shortage from primary sources rather than rumour Replied, post #33 · Access › Shortages · 2 Jun 2026 · 28 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #67 · Practice › Storage & stability · 31 May 2026 · 24 likes Building on post #66 rather than restating it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #52 · Safety › Contraindications · 27 May 2026 · 12 likes Adding the measurement that post #49 says would settle it. Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from…
-
A fridge failure and how I assessed the contents afterwards Replied, post #11 · Devices › Cold chain · 21 May 2026 · 2 likes Post #10 is right about the mechanism and I think understates the practical bit. Arrival condition tells you about the last few hours and very little about the middle…
-
Prescription requirements and telehealth models — a second dataset Replied, post #34 · Sourcing › Regulatory · 18 May 2026 · 9 likes Practical experience of Prescription requirements and telehealth models, offered as one case with the conditions stated, not as a general finding. Conditions first,…
-
The headache that turns out to be dehydration — the long version Replied, post #35 · Nutrition & Training › Hydration & electrolytes · 14 May 2026 · 31 likes Everything in post #33 holds. The case it does not cover is the one I have. Cramping is the symptom most confidently attributed to electrolytes and has the weakest…
-
Travelling with an injectable: documentation and practicalities Replied, post #27 · Access › International · 14 May 2026 · 22 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. A single observation, in a thread…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #2 · Compounds › Oral incretins · 13 May 2026 · 0 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Reading a trial's population section before its results Replied, post #15 · Evidence › Trials · 12 May 2026 · 26 likes Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than adherence outside them.
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #5 · Start Here › How to Ask · 8 May 2026 · 2 likes Everything in post #3 holds. The case it does not cover is the one I have. Quantities without units are the single commonest reason a question sits unanswered. "Two and…
-
Revisiting: Absolute versus relative contraindications Replied, post #82 · Safety › Contraindications · 4 May 2026 · 3 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Official shortage notices and what they authorise Replied, post #30 · Access › Shortages · 2 May 2026 · 0 likes Post #28 and I disagree about the size of the effect, not about the direction. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #23 · Analytics › COA interpretation · 2 May 2026 · 4 likes Everything in post #21 holds. The case it does not cover is the one I have. The arithmetic on field-by-field walk through a certificate is the easy part and it is where…
-
Why 99.2% and 97.8% on the same lot can both be correct Started this topic · Analytics › HPLC & UHPLC · 22 Apr 2026 · 44 likes Why 99.2% and 97.8% on the same lot can both be correct I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to…
-
List price versus negotiated price versus what you pay Replied, post #37 · Access › Pricing · 11 Apr 2026 · 13 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. I keep a log for list price versus negotiated price specifically because my memory…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #78 · Clinical › Bloodwork · 10 Apr 2026 · 17 likes Reference intervals are constructed to contain the central ninety-five per cent of a reference population, so one healthy person in twenty falls outside one by…
-
Spike-and-recover accuracy for a peptide assay Replied, post #70 · Analytics › Method validation · 9 Apr 2026 · 22 likes On post #68 — agreed on the reasoning, with one qualification. Spike-and-recover accuracy was covered in the wiki last year and the page has a review date on it, which…
-
Follow-up: State-level differences that actually matter Replied, post #32 · Regional › North America · 5 Apr 2026 · 30 likes Where I have landed on State-level differences, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Started this topic · Analytics › Impurities & related substances · 3 Apr 2026 · 23 likes Second pass at: Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did.…
-
Reading U-100 graduations, with a conversion table Replied, post #19 · Devices › Syringes & needles · 1 Apr 2026 · 0 likes If your calculated volume is under two graduations, choose a lower concentration rather than trying to read between marks. Precision comes from the preparation, not the…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #84 · Pharmacology › Pharmacokinetics · 27 Mar 2026 · 1 like Thank you — that answers what I came here to find out.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #11 · Data & Tools › Datasets · 23 Mar 2026 · 9 likes Understood. Thank you for being specific about the limits of it.
-
Publication bias detection and its low power — does this still hold? Replied, post #18 · Evidence › Meta-analyses · 18 Mar 2026 · 7 likes Taking Publication bias detection seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #104 · Clinical › Bloodwork · 18 Mar 2026 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Grapefruit: why this class is not the class that cares Replied, post #37 · Practice › Interactions · 13 Mar 2026 · 2 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
-
Contributing data without breaching anyone's privacy Replied, post #65 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes Outliers should be visible in the published data even if excluded from the analysis, with the exclusion rule stated in advance rather than after seeing them. I have…
-
What a certificate commits its issuer to — one year on Replied, post #26 · Analytics › COA interpretation · 3 Mar 2026 · 14 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Choosing which test to pay for, given a fixed budget Replied, post #12 · Sourcing › Independent verification · 3 Mar 2026 · 28 likes Narrowing post #11, because the general version has more than one answer. The record shows what was measured. Everything beyond that is inference and this site tries to…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #133 · Compounds › Semaglutide · 2 Mar 2026 · 6 likes I had written a reply contradicting post #131 and deleted it. Here is what survived. Reframing semaglutide half-life slightly, because I think the disagreement is about…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #21 · Compounds › Tirzepatide · 20 Feb 2026 · 0 likes Reporting rather than recommending, on 2.5 mg starting dose. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #89 · Practice › Dosing & titration · 19 Feb 2026 · 27 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #4 · Devices › Syringes & needles · 10 Feb 2026 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Check what the graduations actually say rather than what you expect. A…
-
[2026 update] Long-time reader, first-time poster Replied, post #49 · Lounge › Introductions · 9 Feb 2026 · 3 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #89 · Access › International · 3 Feb 2026 · 0 likes Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #58 · Meta › Site feedback · 30 Jan 2026 · 13 likes I had written a reply contradicting post #56 and deleted it. Here is what survived. Posting my topic list numbers with the method attached so they can be discounted…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #71 · Practice › Side effects · 19 Jan 2026 · 0 likes Adding the measurement that post #68 says would settle it. Speaking only to muscle cramps as I have actually seen it, rather than as it is usually described: the effect…
-
Aggregates and why a purity assay may miss them entirely Replied, post #61 · Analytics › Impurities & related substances · 9 Jan 2026 · 17 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Preprint servers and what screening they do Replied, post #19 · Evidence › Preprints · 8 Jan 2026 · 27 likes The most useful thing anyone has posted about preprint servers in this category was a table of what had been measured and by whom. That is what I would want again.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #55 · Practice › Side effects · 8 Jan 2026 · 32 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Micro-titration: a disputed topic, argued properly Replied, post #20 · Practice › Dosing & titration · 8 Jan 2026 · 13 likes Answering the question post #16 raises rather than the one it answers. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #19 · Compounds › Oral incretins · 2 Jan 2026 · 20 likes Post #15 describes the usual case. This is about the unusual one. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #124 · Compounds › Oral incretins · 2 Jan 2026 · 4 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #26 · Start Here › Welcome · 31 Dec 2025 · 6 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
-
Reverse causation in a cohort study of weight and outcome Replied, post #10 · Evidence › Study critique · 31 Dec 2025 · 7 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
CJC-1295 with and without DAC: what the modification does — what changed since Replied, post #4 · Compounds › Secretagogues & GH axis · 26 Dec 2025 · 12 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
The decimal-point error, and the habit that catches it Replied, post #106 · Practice › Reconstitution · 18 Dec 2025 · 8 likes My experience of decimal-point error contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
Realistic expectations for strength while losing weight quickly Replied, post #45 · Nutrition & Training › Resistance training · 17 Dec 2025 · 15 likes I read the earlier replies on realistic expectations for strength twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #74 · Compounds › Oral incretins · 16 Dec 2025 · 0 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
-
Tracking a preprint to publication: a worked example Replied, post #123 · Evidence › Preprints · 12 Dec 2025 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. I am aware this is…
-
Personal import allowances, compared — a second dataset Replied, post #32 · Access › International · 6 Dec 2025 · 8 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Tracking a preprint to publication: a worked example Replied, post #39 · Evidence › Preprints · 3 Dec 2025 · 2 likes Post #36 answers the question as asked. The question underneath it is different. Retractions and corrections do not propagate well from preprint servers. A citation…
-
Pen dose counters: what a click does and does not guarantee Replied, post #75 · Devices › Pens & autoinjectors · 17 Nov 2025 · 1 like Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #135 · Practice › Storage & stability · 12 Nov 2025 · 0 likes No notes. Posting so the count is not one.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #77 · Analytics › HPLC & UHPLC · 6 Nov 2025 · 8 likes Detection wavelength: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like…
-
[2026 update] What steady state means for the decision to escalate Replied, post #12 · Practice › Dosing & titration · 5 Nov 2025 · 2 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Coverage in the US: a map of the usual obstacles Replied, post #7 · Regional › North America · 3 Nov 2025 · 0 likes On coverage, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting…
-
How to read a forest plot, properly, from scratch Replied, post #47 · Evidence › Trials · 28 Oct 2025 · 32 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #108 · Practice › Storage & stability · 28 Oct 2025 · 32 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The general…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #121 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #100 · Compounds › Tirzepatide · 23 Oct 2025 · 0 likes Where the SURMOUNT-4 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
-
A payment that went through twice: how it was resolved Replied, post #6 · marked as the solution · Sourcing › Payments · 17 Oct 2025 · 7 likes Ask what happens if the material fails independent testing before you order, not afterwards. The answer is informative and costs one email. I would want a second…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #4 · Outcomes › Body composition · 9 Oct 2025 · 24 likes Post #3 is the version of this I will quote in future. One addition. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean…
-
MHRA statements, read directly Replied, post #12 · Regional › UK & Ireland · 6 Oct 2025 · 29 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #63 · Compounds › Other compounds · 4 Oct 2025 · 17 likes PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #49 · Compounds › Repair & healing peptides · 29 Sep 2025 · 0 likes Post #45 describes the usual case. This is about the unusual one. Worth separating BPC-157 as a question about the compound from BPC-157 as a question about the…
-
Payment method and the leverage it gives you, ranked Replied, post #24 · Sourcing › Payments · 17 Sep 2025 · 9 likes On post #20 — agreed on the reasoning, with one qualification. A methods point on payment method rather than a substantive one: if the comparison is not like for like,…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #116 · Evidence › Study critique · 16 Sep 2025 · 4 likes What I would check first on Reverse causation is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
MHRA statements, read directly Replied, post #3 · Regional › UK & Ireland · 13 Sep 2025 · 1 like The arithmetic on MHRA statements is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #120 · Practice › Reconstitution · 6 Sep 2025 · 1 like Research-use-only material reconstituted at home is not a compounded sterile preparation and nothing about the procedure makes it one. Members describing what they do…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #106 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 8 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #45 · Practice › Side effects · 21 Aug 2025 · 0 likes On post #44 — agreed on the reasoning, with one qualification. I changed my mind about Fatigue after someone here asked me for the source and I could not produce one.…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #85 · Compounds › Oral incretins · 19 Aug 2025 · 23 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
-
Publishing an inconvenient result: a case study Replied, post #63 · Sourcing › Independent verification · 9 Aug 2025 · 21 likes Picking up post #60: that is the part I would want checked first. Repeat determination on the same product line months apart is the measurement that speaks to…
-
Tracking that stops updating and then resumes Replied, post #16 · Sourcing › Logistics · 8 Aug 2025 · 29 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
Realistic expectations for strength while losing weight quickly Replied, post #12 · Nutrition & Training › Resistance training · 6 Aug 2025 · 10 likes My position on realistic expectations for strength is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Are there stupid questions here? A staff answer, at length Replied, post #42 · Start Here › Welcome · 5 Aug 2025 · 23 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #35 · Compounds › Retatrutide · 4 Aug 2025 · 10 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #20 · Practice › Dosing & titration · 2 Aug 2025 · 11 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Travel coolers and how long they really hold Replied, post #23 · Devices › Cold chain · 2 Aug 2025 · 8 likes Taking post #20 at face value and following it one step further. Travel coolers was covered in the wiki last year and the page has a review date on it, which is a…
-
Travel coolers and how long they really hold Replied, post #12 · Devices › Cold chain · 31 Jul 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
How to research a compound with no human data without deceiving yourself Replied, post #15 · Compounds › Other compounds · 30 Jul 2025 · 0 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. A compound with no established assay is a compound where a certificate can say…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #32 · Compounds › Semaglutide · 25 Jul 2025 · 25 likes Nausea is dose-related and adaptation-related, and both are true at once. The pattern most people describe is a return of symptoms at each escalation followed by…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #2 · Compounds › Secretagogues & GH axis · 20 Jul 2025 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 3 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #58 · Evidence › Journal club · 28 Jun 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed CagriSema phase 2 combination paper, as opposed to read about it? The thread is long…
-
What a documentation review can and cannot tell you Replied, post #10 · Sourcing › Independent verification · 20 Jun 2025 · 11 likes Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #19 · Analytics › Method validation · 19 Jun 2025 · 0 likes Filing a mild objection to the consensus on Forced degradation studies. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
-
Regression to the mean in progress reports Replied, post #21 · Research Methods › Statistics · 16 Jun 2025 · 5 likes Post #20 answers the question as asked. The question underneath it is different. What I want from this regression thread is the list of things that would need to be…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #123 · Data & Tools › Calculators · 9 Jun 2025 · 14 likes Where a calculator and your own arithmetic disagree, the productive move is to find which step differs rather than to decide which is right.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #130 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 0 likes Post #126 and I disagree about the size of the effect, not about the direction. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #3 · Compounds › Tirzepatide · 7 Jun 2025 · 19 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Preparing for an appointment: one page, three questions Replied, post #21 · Clinical › Prescriber conversations · 2 Jun 2025 · 5 likes Post #18 is right about the mechanism and I think understates the practical bit. Bringing a record of symptoms with dates and severities makes an assessment materially…
-
An emergency department visit, described afterwards Replied, post #25 · Safety › Adverse events · 28 May 2025 · 0 likes Worth separating two things that post #21 runs together. Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the…
-
Albumin binding and how it produces a long half-life Replied, post #41 · Pharmacology › Pharmacokinetics · 27 May 2025 · 0 likes The number people quote for albumin binding is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #48 · Practice › Storage & stability · 24 May 2025 · 3 likes The arithmetic in post #45 is right; the assumption feeding it is the part to check. Visible particulate is a strong signal in the other direction: it is a reason to…
-
A well-designed study with a badly written abstract Replied, post #66 · Evidence › Study critique · 7 May 2025 · 14 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Coverage for the indication versus for the drug Replied, post #52 · Access › Insurance & coverage · 4 May 2025 · 8 likes Having read the whole coverage thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
-
A ten-fold dose error caught before injection Replied, post #29 · Devices › Syringes & needles · 3 May 2025 · 16 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #82 · Sourcing › Red flags · 18 Apr 2025 · 3 likes On post #78 — agreed on the reasoning, with one qualification. Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #3 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 33 likes Picking up the opening post: that is the part I would want checked first. Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #56 · Access › Pricing · 6 Apr 2025 · 8 likes Post #52 describes the usual case. This is about the unusual one. Price variation between pharmacies: identical prescriptions can cost different amounts at different…
-
A certificate with no method stated: what can you conclude? Replied, post #28 · Analytics › COA interpretation · 4 Apr 2025 · 2 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Requesting a page: what makes a good request Replied, post #32 · Documentation › Wiki requests · 23 Mar 2025 · 2 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Counter-ion content and its effect on measured mass Replied, post #4 · Analytics › Mass spectrometry · 22 Mar 2025 · 0 likes Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #8 · Sourcing › Vendor reports · 14 Mar 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #25 · Compounds › Tirzepatide · 14 Mar 2025 · 16 likes On post #23 — agreed on the reasoning, with one qualification. The claim about GIP component of tirzepatide upthread is stronger than its source supports. I have read…
-
An emergency department visit, described afterwards Replied, post #2 · Safety › Adverse events · 5 Mar 2025 · 24 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #119 · Compounds › Semaglutide · 2 Mar 2025 · 0 likes Counterpoint on Semaglutide half-life, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #4 · Evidence › Journal club · 26 Feb 2025 · 0 likes STEP 4 is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Reading order for a first week here, and what to skip until later Replied, post #5 · Start Here › Welcome · 14 Feb 2025 · 28 likes Reading order is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #9 · Compounds › Tirzepatide · 23 Jan 2025 · 17 likes On post #7 — agreed on the reasoning, with one qualification. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #8 · Compounds › Repair & healing peptides · 22 Jan 2025 · 0 likes Answering the question post #4 raises rather than the one it answers. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #19 · Practice › Interactions · 21 Jan 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Anaesthesia and elective surgery, because it is the sort of…
-
What we do not know about retatrutide, listed explicitly Replied, post #63 · Compounds › Retatrutide · 20 Jan 2025 · 6 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
-
[2026 update] New subcategory: rationale and scope Replied, post #136 · Meta › Announcements · 10 Jan 2025 · 0 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #11 · Pharmacology › Receptor biology · 25 Dec 2024 · 0 likes The most useful reply I ever got about Biased agonism was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #14 · Practice › Reconstitution · 24 Dec 2024 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #13 · Data & Tools › Calculators · 7 Dec 2024 · 32 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Washout with a one-week half-life: the arithmetic Replied, post #73 · Research Methods › N-of-1 designs · 5 Dec 2024 · 25 likes A rolling mean over several days is far more informative than any single reading for anything that varies day to day, which is nearly everything.
-
Reading a supplementary appendix and finding the interesting part Replied, post #35 · Evidence › Trials · 2 Dec 2024 · 27 likes The arithmetic in post #34 is right; the assumption feeding it is the part to check. Risk of bias: structured appraisal of internal validity. Key things to assess:…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #46 · Compounds › Tirzepatide · 20 Nov 2024 · 17 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. Titration schedules for tirzepatide have more dose steps than…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #30 · Compounds › Repair & healing peptides · 11 Nov 2024 · 0 likes Everything in post #26 holds. The case it does not cover is the one I have. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake…
-
Blind submission and why it changes minds Replied, post #94 · Sourcing › Independent verification · 21 Oct 2024 · 0 likes I had written a reply contradicting post #90 and deleted it. Here is what survived. An observation about blind submission that I cannot explain and am posting anyway,…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #27 · Compounds › Semaglutide · 17 Oct 2024 · 0 likes Post #26 is the version of this I will quote in future. One addition. An observation about Semaglutide half-life that I cannot explain and am posting anyway, on the…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #50 · Compounds › Semaglutide · 13 Sep 2024 · 5 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #6 · Compounds › Retatrutide · 27 Aug 2024 · 20 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…